Table 2.
In vivo antioxidant activities of COS.
| Sample | Assay | Effect | Reference |
|---|---|---|---|
| COS | High-fat diet (HFD) mouse model; superoxide radical scavenging activity; hydroxyl radical scavenging and DPPH assay | Reduction of the oxidative damage resulted from the HFD. | [39] |
|
| |||
| Chitooligomers with degrees of polymerization | Measurement of reducing power; hydroxyl radical scavenging assay | Increase of SOR scavenging potential of chitooligomers accompanying several degrees of polymerization. | [42] |
|
| |||
| COS | Estimation of O2 and H2O2; flow cytometric analysis to assess neutrophil apoptosis | Neutrophils' proapoptotic capacity from glycogen-mediated peritonitis in mice model; inhibition of SOR generation; reduction of the myeloperoxidase liberation. | [43] |
|
| |||
| COS | Histological study and retinal cell count; estimation of NeuN-positive ganglion cell layer neurons; terminal deoxynucleotidyl transferase-induced dUTP biotinide end labeling (TUNEL); cell culturing of RGC-5 and in vitro oxidative damage | Preventing ischemia of retina through decreasing oxidative and inflammatory conditions. | [44] |
|
| |||
| COS | Determination of GSH, MDA contents, and SOD activity; evaluation of neuronal apoptosis through TUNEL assay; immunohistochemical analysis of 8-OHdG, IL-1b, and TNF-α | Amyloid-1–42-induced rat model of Alzheimer's disease; antioxidant activity in hippocampus, effects on apoptosis (TUNEL assay); inhibition of neuroinflammatory responses. | [45] |
|
| |||
| Chitin, chitosan, COS and N-acetyl-D-glucosamine | Measurement of antioxidant defense parameters; determination of antioxidant enzyme activity; MDA and carbonyl protein assays | Dietary intake containing COS could enhance the growth performance of P. monodon and improve its resistance to DO stress on shrimp, Penaeus monodon. | [46] |
|
| |||
| COS | Measurement of antibacterial activities of COS; measurement for the resistance to COS after long-term culture; biochemical analysis; RT-PCR and western blot analysis | Reduction of antibiotics dose; prevention of antibiotics-caused side effects in adolescent idiopathic scoliosis (AIS) patients with spinal fusion surgery. | [47] |
|
| |||
| COS | Measurements of antioxidant-related indices; analyses of cytokines and immunoglobulins; duodenal, jejunal, and ileal histomorphological studies; intestinal mucosal digestive enzymes assay and sIgA; extraction of total RNA and reverse transcription reactions; PCR and microbial population determination | Enhancing growth performance, antioxidant capacity, immunity, and intestinal development of weaned pigs. | [48] |
|
| |||
| N-acetyl COS | DPPH assay and production of N-acetyl COS; measurement of enzyme activity | Production of antioxidants and N-acetyl COS by Serratia sp.; TKU020 fermentation. | [49] |
|
| |||
| COS | Drug-metabolizing enzyme activity; estimation of lipid peroxide and GSH levels and GSH S-transferase and NQO1 activity; western blot analysis | Suppression of hepatic CYP enzymes and enhancement of phase II detoxifying reactions of hepato and renal cells in vivo. | [50] |
|
| |||
| COS | Cell culture; nitrite assay; measurement of TNF-α; spectrofluorometric assay of RDPase; protein and creatinine assay; SOD and MDA assay | COS stimulated the production of TNF-α, NO, and RDPase. | [51] |
|
| |||
| COS | Measurement of antioxidant enzyme's activities or oxidant injury product; RNA isolation and real-time polymerase chain reaction | Increase of antioxidant defense capacity and placental amino acid transport of sows. | [52] |